Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

beclobrinic acid

Known as: 2-(4 ((4-chlorophenyl)methyl)phenoxy)-2-methyl butanoic acid, beclobric acid 
 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2009
2009
The effect of hypolipidaemic compounds on peroxisomal fatty acid β-oxidation and on peroxisome morphology in the liver differs… Expand
  • figure I
  • table 1
  • figure 2
  • table 2
  • figure 3
Is this relevant?
1993
1993
Acyl glucuronides are known to be labile conjugates, which undergo hydrolysis and bind irreversibly to proteins. The lipid… Expand
Is this relevant?
1993
1993
The chiral lipid regulating agent beclobrate (CAS 55937-99-0), which was marketed as racemate, is - like clofibrate - rapidly… Expand
Is this relevant?
1991
1991
The major biotransformation pathway for the chiral lipid-regulating agent beclobrate is conversion to the corresponding… Expand
Is this relevant?
1990
1990
The peroxisome-proliferating effects of clofibric acid and beclobric acid were studied in primary cultures of hepatocytes derived… Expand
Is this relevant?
1990
1990
The lipid-reducing effects of a new fibric acid derivative (beclobrate, 100 mg/day), L-carnitine (15 mg/ kg b.w. thrice weekly i… Expand
Is this relevant?
1987
1987
Beclobrate [2-(4-[(4-chlorophenyl)methyl]phenoxy)-2-methylbutyric acid ethyl ester], a structural analog of clofibrate, is used… Expand
Is this relevant?
1987
1987
The pharmacokinetics of beclobrate (ethyl(+/-)-2-[[alpha-(p-chlorophenyl)-p-tolyl]-oxy]-2-methylbutyrate, SGD 24774), a new lipid… Expand
Is this relevant?
1985
1985
Effects and the mechanism of the antiplatelet actions of beclobrinic acid, free acid form of a new hypolipidemic agent beclobrate… Expand
Is this relevant?
1985
1985
The major pathway of biotransformation of beclobrate [(2-[4-[(4-chlorophenyl)methyl]phenoxy]-2-methylbutyric acid ethyl ester] is… Expand
Is this relevant?